» Articles » PMID: 19922906

Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2009 Nov 20
PMID 19922906
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several lines of evidence suggest that major depressive disorder is associated with deficits in gamma-aminobutyric acid (GABA) inhibitory neurotransmission. Transcranial magnetic stimulation represents a noninvasive technique to measure cortical inhibition. In this study, we endeavored to measure cortical inhibition in medicated patients with treatment resistant major depressive disorder (TRD), unmedicated patients with major depressive disorder, and medicated euthymic patients with a history of major depressive disorder and compare them with healthy subjects.

Methods: Twenty-five patients with TRD, 16 unmedicated patients with major depressive disorder, 19 medicated euthymic patients with previous major depressive disorder (i.e., 17-item Hamilton Rating Scale for Depression < 8), and 25 healthy subjects were enrolled. Cortical inhibition was measured with transcranial magnetic stimulation paradigms known as short-interval cortical inhibition and the cortical silent period, which index GABA(A) and GABA(B) receptor-mediated inhibitory neurotransmission, respectively.

Results: All major depressive disorder patient groups demonstrated significant cortical silent period deficits compared with healthy subjects. By contrast, only TRD patients demonstrated significant deficits in short-interval cortical inhibition compared with healthy subjects, medicated euthymic major depressive disorder patients, and unmedicated major depressive disorder patients. The TRD patients also demonstrated a significantly greater resting motor threshold compared with all other clinical subgroups and healthy subjects, suggesting that TRD was also associated with hypoexcitability of the frontal cortex.

Conclusions: Our findings suggest that GABA(B) neurophysiological deficits are closely related to pathophysiology of major depressive disorder. Our findings also suggest that more severe illness is selectively associated with GABA(A) receptor-mediated inhibitory deficits.

Citing Articles

Therapeutic dose prediction of α5-GABA receptor modulation from simulated EEG of depression severity.

Guet-McCreight A, Mazza F, Prevot T, Sibille E, Hay E PLoS Comput Biol. 2024; 20(12):e1012693.

PMID: 39729407 PMC: 11676559. DOI: 10.1371/journal.pcbi.1012693.


Characteristic Changes of Prefrontal and Motor Areas in Patients with Type 2 Diabetes and Major Depressive Disorder During a Motor Task of Tai Chi Chuan: A Functional Near-Infrared Spectroscopy Study.

Zhang J, Li Y, Liu X, Zhong D, Xue C, Fan J Brain Behav. 2024; 14(10):e70071.

PMID: 39378277 PMC: 11460607. DOI: 10.1002/brb3.70071.


The Antidepressant Action of Fluoxetine Involves the Inhibition of in Cortical GABAergic Neurons through a TrkB-Dependent Pathway.

Aouci R, Fontaine A, Vion A, Belz L, Levi G, Narboux-Neme N Cells. 2024; 13(15.

PMID: 39120293 PMC: 11311550. DOI: 10.3390/cells13151262.


Sex-specific GABAergic microcircuits that switch vulnerability into resilience to stress and reverse the effects of chronic stress exposure.

Luscher B, Jiang T, Feng M, Hutsell A Res Sq. 2024; .

PMID: 39041032 PMC: 11261964. DOI: 10.21203/rs.3.rs-4408723/v1.


[Saikosaponin a alleviates pentylenetetrazol-induced acute epileptic seizures in mouse models of depression by suppressing microglia activation-mediated inflammation].

Xiong Y, Liang X, Li W, Qian Y, Xie W Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(3):515-522.

PMID: 38597443 PMC: 11006703. DOI: 10.12122/j.issn.1673-4254.2024.03.13.